Cross-cultural Adaptation of the 'Cold Intolerance Severity Score' (CISS) to the Dutch Language.
Launched by ERASMUS MEDICAL CENTER · Jun 22, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on adapting a tool called the Cold Intolerance Severity Score (CISS) for Dutch-speaking patients. The CISS helps doctors understand how cold temperatures affect people who have suffered from hand injuries. The goal is to gather information about how severe cold intolerance is in patients who have experienced traumatic hand injuries, particularly in cases that may involve legal aspects.
To participate in this study, you need to be an adult with a traumatic hand injury and have a good understanding of the Dutch language. Unfortunately, if you have had a total amputation of your hand, you won't be eligible. If you join the trial, you will be asked to complete the CISS questionnaire, which will help researchers gather important information about your condition. The trial is currently looking for participants, and anyone interested can reach out for more details.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Adult
- • Traumatic hand injury
- • Sufficient knowledge of the Dutch language (at least level B1)
- Exclusion Criteria:
- • - Definitive total hand amputation
About Erasmus Medical Center
Erasmus Medical Center, located in Rotterdam, Netherlands, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution within the Erasmus University Rotterdam, the center integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a wide range of medical specialties. With a strong emphasis on multidisciplinary collaboration, Erasmus Medical Center aims to translate research findings into tangible clinical applications, enhancing treatment options and improving patient outcomes. The institution is dedicated to conducting ethical and rigorous clinical trials that contribute to the global body of medical knowledge and foster advancements in personalized medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rotterdam, Zuid Holland, Netherlands
Patients applied
Trial Officials
Reinier Feitz, MD PhD
Principal Investigator
Erasmus Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported